Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/37141
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Beckthold B. | en |
dc.contributor.author | Kaye S. | en |
dc.contributor.author | Land S. | en |
dc.contributor.author | Walker S. | en |
dc.contributor.author | Haubrich R. | en |
dc.contributor.author | DeJesus E. | en |
dc.contributor.author | Berthon-Jones N. | en |
dc.contributor.author | Espinosa N. | en |
dc.contributor.author | Courtney-Vega K. | en |
dc.contributor.author | Absar N. | en |
dc.contributor.author | Haskelberg H. | en |
dc.contributor.author | Ubolyam S. | en |
dc.contributor.author | Gambardella L. | en |
dc.contributor.author | Valdovinos M. | en |
dc.contributor.author | Arnaiz J. | en |
dc.contributor.author | Beleta H. | en |
dc.contributor.author | Ramos N. | en |
dc.contributor.author | Targa M. | en |
dc.contributor.author | Boesecke C. | en |
dc.contributor.author | Engelhardt A. | en |
dc.contributor.author | Bloch M. | en |
dc.contributor.author | Callau P. | en |
dc.contributor.author | Perry N. | en |
dc.contributor.author | Drummond F. | en |
dc.contributor.author | Lefevre E. | en |
dc.contributor.author | Corr S. | en |
dc.contributor.author | Grant C. | en |
dc.contributor.author | Lupo S. | en |
dc.contributor.author | Peroni L. | en |
dc.contributor.author | Sanchez M. | en |
dc.contributor.author | De Paz Sierra M. | en |
dc.contributor.author | Viloria G. | en |
dc.contributor.author | Aldeguer J.L. | en |
dc.contributor.author | Franic T. | en |
dc.contributor.author | Parlante A. | en |
dc.contributor.author | Bissio E. | en |
dc.contributor.author | Luchetti P. | en |
dc.contributor.author | Confalonieri V. | en |
dc.contributor.author | Warley E. | en |
dc.contributor.author | Vieni I. | en |
dc.contributor.author | Vilas C. | en |
dc.contributor.author | Zarate A. | en |
dc.contributor.author | Mayer G. | en |
dc.contributor.author | Tovar S.C. | en |
dc.contributor.author | Elliot J. | en |
dc.contributor.author | Vincent T. | en |
dc.contributor.author | Hagenauer M. | en |
dc.contributor.author | Kelley M. | en |
dc.contributor.author | Rowling D. | en |
dc.contributor.author | Gibson A. | en |
dc.contributor.author | Latch N. | en |
dc.contributor.author | Stewart N. | en |
dc.contributor.author | Jayewardene A. | en |
dc.contributor.author | Dwyer D. | en |
dc.contributor.author | Noval M.L. | en |
dc.contributor.author | Kok J. | en |
dc.contributor.author | Assam D. | en |
dc.contributor.author | Taylor J. | en |
dc.contributor.author | King P. | en |
dc.contributor.author | Orth D. | en |
dc.contributor.author | Youds D. | en |
dc.contributor.author | Sowden D. | en |
dc.contributor.author | Johnston C. | en |
dc.contributor.author | Murray S. | en |
dc.contributor.author | Hehir J. | en |
dc.contributor.author | Rivas I. | en |
dc.contributor.author | Wadham S. | en |
dc.contributor.author | Donohue W. | en |
dc.contributor.author | Thompson J. | en |
dc.contributor.author | Garsia R. | en |
dc.contributor.author | Turnham G. | en |
dc.contributor.author | Madden T. | en |
dc.contributor.author | Nvene J. | en |
dc.contributor.author | Gillies A. | en |
dc.contributor.author | Bryant M. | en |
dc.contributor.author | Walmsley S. | en |
dc.contributor.author | Delgado-Fernandez M. | en |
dc.contributor.author | Chan W. | en |
dc.contributor.author | LeBlanc R. | en |
dc.contributor.author | Lanteigne F. | en |
dc.contributor.author | Mouawad R. | en |
dc.contributor.author | Rahal I. | en |
dc.contributor.author | Guber S. | en |
dc.contributor.author | Ozturk S. | en |
dc.contributor.author | Smith G. | en |
dc.contributor.author | Halpenny R. | en |
dc.contributor.author | Reko T. | en |
dc.contributor.author | Arribas J.R. | en |
dc.contributor.author | Hills J.R. | en |
dc.contributor.author | Allendes G. | en |
dc.contributor.author | Hocqueloux F.L. | en |
dc.contributor.author | Stephan C. | en |
dc.contributor.author | Ebeling F. | en |
dc.contributor.author | Spath B. | en |
dc.contributor.author | Jensen B.-E.O. | en |
dc.contributor.author | Feind C. | en |
dc.contributor.author | Meyer-Olson D. | en |
dc.contributor.author | Stoll M. | en |
dc.contributor.author | Castro J.M. | en |
dc.contributor.author | Hoeper K. | en |
dc.contributor.author | Beider R. | en |
dc.contributor.author | Faetkenheur G. | en |
dc.contributor.author | Thomas E. | en |
dc.contributor.author | Baumgarten A. | en |
dc.contributor.author | Ingiliz P. | en |
dc.contributor.author | Wienbreyer A. | en |
dc.contributor.author | Behrendt D. | en |
dc.contributor.author | Nienkarken T. | en |
dc.contributor.author | Jessen H. | en |
dc.contributor.author | Avihingsanon A. | en |
dc.contributor.author | Zedlack C. | en |
dc.contributor.author | Simelane S. | en |
dc.contributor.author | Assmann J. | en |
dc.contributor.author | Ghavami-Kia B. | en |
dc.contributor.author | Imahashi M. | en |
dc.contributor.author | Tanabe K. | en |
dc.contributor.author | Yokomaku Y. | en |
dc.contributor.author | Imamura J. | en |
dc.contributor.author | de Oca M.M. | en |
dc.contributor.author | Gonzalez L. | en |
dc.contributor.author | Maek-a-nantawat W. | en |
dc.contributor.author | Ponce D. | en |
dc.contributor.author | Mendoza A. | en |
dc.contributor.author | Sierra-Madero J. | en |
dc.contributor.author | Hernandez J.E.S. | en |
dc.contributor.author | Ballesteros E.J.R. | en |
dc.contributor.author | del Moral Ponce S. | en |
dc.contributor.author | Ignatowska A. | en |
dc.contributor.author | Bakowska E. | en |
dc.contributor.author | Pulik P. | en |
dc.contributor.author | Sanz-Moreno J. | en |
dc.contributor.author | Robson R. | en |
dc.contributor.author | Paredes R. | en |
dc.contributor.author | Puig J. | en |
dc.contributor.author | Domingo P. | en |
dc.contributor.author | Gutierrez M. | en |
dc.contributor.author | Gonzalez-Cordon A. | en |
dc.contributor.author | Intasan J. | en |
dc.contributor.author | Charoenporn W. | en |
dc.contributor.author | Cuprasitrut T. | en |
dc.contributor.author | Jaisomkom P. | en |
dc.contributor.author | Pruksakaew K. | en |
dc.contributor.author | Winston A. | en |
dc.contributor.author | Mullaney S. | en |
dc.contributor.author | Barbour L. | en |
dc.contributor.author | Richardson C. | en |
dc.contributor.author | Fox J. | en |
dc.contributor.author | Donaldson A. | en |
dc.contributor.author | Murray T. | en |
dc.contributor.author | Teague A. | en |
dc.contributor.author | Leen C. | en |
dc.contributor.author | Morris S. | en |
dc.contributor.author | Satyajit D. | en |
dc.contributor.author | Sandhu R. | en |
dc.contributor.author | Tucker J. | en |
dc.contributor.author | Pett S. | en |
dc.contributor.author | Amin J. | en |
dc.contributor.author | Horban A. | en |
dc.contributor.author | Guelman D. | en |
dc.contributor.author | Andrade-Villanueva J. | en |
dc.contributor.author | Losso M. | en |
dc.contributor.author | Porteiro N. | en |
dc.contributor.author | Madero J.S. | en |
dc.contributor.author | Belloso W. | en |
dc.contributor.author | Tu E. | en |
dc.contributor.author | Silk D. | en |
dc.contributor.author | Kelleher A. | en |
dc.contributor.author | Harrigan R. | en |
dc.contributor.author | Clark A. | en |
dc.contributor.author | Tabrett C. | en |
dc.contributor.author | Sugiura W. | en |
dc.contributor.author | Wolff M.J. | en |
dc.contributor.author | Gill J. | en |
dc.contributor.author | Gatell J. | en |
dc.contributor.author | Clarke A. | en |
dc.contributor.author | Ruxrungtham K. | en |
dc.contributor.author | Prazuck T. | en |
dc.contributor.author | Kaiser R. | en |
dc.contributor.author | Woolley I. | en |
dc.contributor.author | Alberto Arnaiz J. | en |
dc.contributor.author | Warzywoda E. | en |
dc.contributor.author | Cooper D. | en |
dc.contributor.author | Rockstroh J.K. | en |
dc.contributor.author | Mallon P. | en |
dc.contributor.author | Emery S. | en |
dc.contributor.author | Fisher M. | en |
dc.contributor.author | Rockstroh J. | en |
dc.contributor.author | Stellbrink J. | en |
dc.contributor.author | Merlin K. | en |
dc.contributor.author | Yeung J. | en |
dc.contributor.author | Fsadni B. | en |
dc.contributor.author | MacRae K. | en |
dc.contributor.author | Marks K. | en |
dc.contributor.author | Suzuki K. | en |
dc.contributor.author | Rismanto N. | en |
dc.contributor.author | Salomon H. | en |
dc.contributor.author | Rubio A.E. | en |
dc.contributor.author | Chibo D. | en |
dc.contributor.author | Birch C. | en |
dc.contributor.author | Swenson L. | en |
dc.contributor.author | Chan D. | en |
dc.contributor.author | Berg T. | en |
dc.contributor.author | Sinclair B. | en |
dc.contributor.author | Obermeier M. | en |
dc.contributor.author | Schuelter E. | en |
dc.contributor.author | Aragon S.S. | en |
dc.contributor.author | Luebke N. | en |
dc.contributor.author | Coughlan S. | en |
dc.contributor.author | Dean J. | en |
dc.contributor.author | Iwatani Y. | en |
dc.contributor.author | Teran G.R. | en |
dc.contributor.author | Avila S. | en |
dc.contributor.author | Sirivichayakul S. | en |
dc.contributor.author | Sinn K. | en |
dc.contributor.author | Naphassanant M. | en |
dc.date.accessioned | 2021-05-14T12:37:31Z | en |
dc.date.available | 2021-05-14T12:37:31Z | en |
dc.date.copyright | 2018 | en |
dc.date.created | 20171219 | en |
dc.date.issued | 2017-12-19 | en |
dc.identifier.citation | HIV Medicine. 19 (1) (pp 65-71), 2018. Date of Publication: January 2018. | en |
dc.identifier.issn | 1464-2662 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/37141 | en |
dc.description.abstract | Objectives: The Maraviroc Switch (MARCH) study week 48 data demonstrated that maraviroc, a chemokine receptor-5 (CCR5) inhibitor, was a safe and effective switch for the ritonavir-boosted protease inhibitor (PI/r) component of a two nucleos(t)ide reverse transcriptase inhibitor [N(t)RTI] plus PI/r-based antiretroviral regimen in patients with R5-tropic virus. Here we report the durability of this finding. Method(s): MARCH, an international, multicentre, randomized, 96-week open-label switch study, enrolled HIV-1-infected adults with R5-tropic virus who were stable (> 24 weeks) and virologically suppressed [plasma viral load (pVL) < 50 HIV-1 RNA copies/mL]. Participants were randomized to continue their current PI/r-based regimen (PI/r) or to switch to MVC plus two N(t)RTIs (MVC) (1:2 randomization). The primary endpoint was the difference in the proportion with pVL < 200 copies/mL at 96 weeks. The switch arm was defined as noninferior if the lower limit of the 95% confidence interval (CI) for the difference was < -12% in the intention-to-treat (ITT) population. Safety endpoints (the difference in the mean change from baseline or a comparison of proportions) were analysed as key secondary endpoints. Result(s): Eighty-two (PI/r) and 156 (MVC) participants were randomized and included in the ITT analysis; 71 (87%) and 130 (83%) were in follow-up and on therapy at week 96. At week 96, 89.0% and 90.4% in the PI/r and MVC arms, respectively, had pVL < 50 copies/mL (95% CI -6.6, 10.2). Moreover, in those switching away from PI/r, there were significant reductions in mean total cholesterol (differences 0.31 mmol/L; P = 0.02) and triglycerides (difference 0.44 mmol/L; P < 0.001). Changes in CD4 T-cell count, renal function, and serious and nonserious adverse events were similar in the two arms. Conclusion(s): MVC as a switch for a PI/r is safe and effective at maintaining virological suppression while having significant lipid benefits over 96 weeks.Copyright © 2017 British HIV Association | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Blackwell Publishing Ltd (E-mail: customerservices@oxonblackwellpublishing.com) | en |
dc.relation.ispartof | HIV Medicine | en |
dc.title | Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. | en |
dc.type | Article | en |
dc.identifier.affiliation | Infectious Diseases and Clinical Microbiology | - |
dc.type.studyortrial | Randomised controlled trial | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/hiv.12532 | en |
dc.publisher.place | United Kingdom | en |
dc.identifier.pubmedid | 28703491 [http://www.ncbi.nlm.nih.gov/pubmed/?term=28703491] | en |
dc.identifier.source | 617328463 | en |
dc.identifier.institution | (Pett, Amin, Tu, Silk, Kelleher, Cooper, Emery) The Kirby Institute, UNSW Australia, Sydney, NSW, Australia (Pett) Institutes of Clinical Trials and Methodology, University College London, London, United Kingdom (Pett) Clinical Research Group, Infection and Population Health, Institute for Global Health, University College London, London, United Kingdom (Horban) Wojewodzki Szpital Zakazny Centre for AIDS therapy and Diagnosis, Warsaw, Poland (Andrade-Villanueva) Hospital Civil de Guadalajara "Fray Antonio Alcalde", Jalisco, Mexico (Losso) Hospital General de Agudos J M Ramos Mejia, Buenos Aires, Argentina (Losso, Belloso) Fundacion IBIS CICAL, Buenos Aires, Argentina (Porteiro) Fundacion IDEAA, Buenos Aires, Argentina (Madero) Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico (Belloso) Hospital Italiano de Buenos Aires, Buenos Aires, Argentina (Kelleher, Cooper) St Vincent's Hospital, Sydney, NSW, Australia (Harrigan) BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada (Clark) ViiV Healthcare Ltd, London, United Kingdom (Sugiura) Nagoya Medical Centre, Nagoya, Japan (Wolff) Fundacion Arriaran, Santiago, Chile (Gill) Southern Alberta Clinic, Calgary, AB, Canada (Gatell) Hospital Clinic de Barcelona, Barcelona, Spain (Clarke) Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom (Ruxrungtham) HIV-NAT, Thai Red Cross AIDS Research Center, Australia (Ruxrungtham) Chulalongkorn University, Bangkok, Thailand (Prazuck) Orleans Hospital (CHR Orleans La Source), Orleans, France (Kaiser) Institut fur Virologie, Cologne, Germany (Woolley) Monash Medical Centre and Monash University, Melbourne, Vic, Australia (Alberto Arnaiz) Fundacion Clinic Spain CTU, Barcelona, Spain (Rockstroh) Department of Medicine I, University Hospital Bonn, Bonn, Germany (Mallon) School of Medicine, University College Dublin, Dublin, Ireland (Emery) Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia | en |
dc.description.address | S.L. Pett, The Kirby Institute, UNSW Australia, Sydney, NSW, Australia. E-mail: spett@kirby.unsw.edu.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2019 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | HIV-1 maraviroc protease inhibitor switch | en |
dc.identifier.authoremail | Pett S.L.; spett@kirby.unsw.edu.au | en |
dc.description.grant | Organization: *Abbott Fund* Country: United States Organization: *AbbVie* Country: United States Organization: (BMS) *Bristol-Myers Squibb* Country: United States Organization: (BMS) *British Microcirculation Society* Country: United Kingdom Organization: (BMS) *British Mycological Society* Country: United Kingdom Organization: *Department of Health, Australian Government* Country: Australia Organization: *Gilead Sciences* Country: United States Organization: (GSK) *GlaxoSmithKline* Country: United Kingdom Organization: (GSK) *GlaxoSmithKline foundation* Country: United Kingdom Organization: *Merck* Country: United States Organization: (MSD) *Merck Sharp and Dohme* Country: United Kingdom Organization: (MSD) *Mount Sylvia Diatomite* Country: Australia Organization: *Pfizer* Country: United States Organization: (TRF) *Thailand Research Fund* Country: Thailand Organization: *ViiV Healthcare* Country: United Kingdom Organization: *ViiV Healthcare* Country: United Kingdom | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | Breast Services | - |
crisitem.author.dept | Infectious Diseases and Clinical Microbiology | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.